In NSCLC, four missense mutations of FADD were detected in 80 samples (5%) [50], whereas only one FADD mutation was found in 98 colorectal adenocarcinomas (1%) and no FADD mutation was detected in 116 advanced gastric adenocarcinomas [51]. The gene discussed is FADD; the disease is non-small cell lung carcinoma.